Table 3 Clinical information of rectal cancer patients used in this study
From: ¹H NMR-based metabolic profiling of human rectal cancer tissue
Rectal cancer patients | Normal controls | |
|---|---|---|
Number | 127 | 43 |
Age (median,range) | 55 28-86 | 56 35-85 |
Male/female ration | 69/58 | 16/27 |
Histology | Adenocarcinoma(127) | ∕ |
Pathologic grade | ∕ | |
PD | 36 | |
MD | 80 | |
WD | 7 | |
NA | 4 | |
Cancer stage/Duke | ∕ | |
I/A(35) | T1N0M0(10) | |
T2N0M0(25) | ||
II/B(37) | T3N0M0(37) | |
III/C(37) | T2N1aM0(3) | |
T2N2aM0(2) | ||
T3N1aM0(16) | ||
T3N1bM0(8) | ||
T3N2aM0(4) | ||
T3N2bM0(4) | ||
IV/D(18) | T3N0M1a(1) | |
T3N1aM1a(1) | ||
T3N1bM1a(5) | ||
T3N2aM1a(5) | ||
T3N2bM1a(5) | ||
T4aN2bM1a(1) | ||
Metastatic site | ∕ | |
I | 35(0) | |
II | 37(0) | |
III | 37(lymph node) | |
IV | 18(liver) |